Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | APAF1 | O14727 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | GALK1 | P51570 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6726810 | 0.88 | MEN1 (0.42) | PGRMAPTMEN1APAF1NPC1 | |
| SCHEMBL19929759 | 0.83 | PGR (0.45) | PGRMAPTMEN1APAF1NPC1 | |
| SCHEMBL18594073 | 0.82 | MAPT (0.39) | PGRMAPTMEN1APAF1NPC1 | |
| SCHEMBL21173403 | 0.82 | PGR (0.44) | PGRMAPTMEN1NPC1LMNA | |
| SCHEMBL3786439 | 0.80 | PGR (0.43) | PGRMAPTMEN1APAF1NPC1 | |
| SCHEMBL30111058 | 0.80 | PGR (0.43) | PGRMAPTMEN1LMNAKMT2A | |
| SCHEMBL29926882 | 0.80 | ALOX5 (0.59) | PGRKMT2ARXRARXRBALOX5 | |
| SCHEMBL16559082 | 0.79 | PGR (0.49) | PGRMAPTMEN1APAF1NPC1 | |
| SCHEMBL1254512 | 0.78 | ALDH1A1 (0.45) | PGRMAPTMEN1LMNAKMT2A | |
| SCHEMBL29433183 | 0.78 | ALDH1A1 (0.45) | PGRMAPTMEN1LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12041848-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
| US-20180066000-A1 | Metal Complexes and Electroluminescent Devices Comprising These Metal Complexes | MERCK PATENT GMBH (DE) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12041848-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | PGR 1452/4885MAPT 746/4885MEN1 798/4885 |
| US-20180066000-A1 | Metal Complexes and Electroluminescent Devices Comprising These Metal Complexes | OCIAD2, OCIAD1, ICOSLG | PGR 3319/4885MAPT 1029/4885MEN1 3880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.